Gene Therapy & Cell Therapy

Center for Education & Bioanalytical Insights

Our scientists share their expert perspectives on evolving methods
and trends in cell & gene therapy bioanalysis.

Learn. Share. Discuss. Innovate Together.

It seems we can't find what you're looking for.
Have a Specific Question?

See how we apply our specialized large molecule expertise to help solve your bioanalytical challenges.

Industry News on Gene & Cell Therapy Innovation

Ready to Join?

Submit your resume today!

Did you know BioAgilytix has supported more than 20 cell and gene therapy programs?

Our proven track record means you can be confident in our deep and specialized expertise to guide your promising gene and cell therapeutics through complex bioanalytical testing phases.

Our experience in gene therapy bioanalysis spans in vivo and ex vivo studies, with specialized expertise developing robust and novel bioanalytical methods to understand the distribution, function, efficacy, and immunogenicity of innovative gene therapeutic candidates in line with regulatory requirements. We have also been successfully supporting cell therapy programs involving TIL, TCR,

CAR, and other innovative modalities across a variety of delivery mechanisms and matrices for over 10 years. BioAgilytix is additionally experienced in developing bioanalytical strategies to investigate the mechanisms of oncolytic virus immunotherapies, from their antitumor properties to immune interaction effects.

We are able to offer deep GxP regulatory knowledge and proven capabilities to support these studies from preclinical phases through clinical trials and post-marketing surveillance. We leverage comprehensive expertise, a state-of-the-art platform suite, and a proven regulatory track record to efficiently progress your gene therapy or cell therapy through all phases of development – tailoring our bioanalytical package to your unique study requirements.

Explore Our platforms

Schedule a Meeting

See regulatory expertise